GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rayont Inc (OTCPK:RAYT) » Definitions » Sloan Ratio %

Rayont (Rayont) Sloan Ratio % : 59.19% (As of Mar. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Rayont Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Rayont's Sloan Ratio for the quarter that ended in Mar. 2023 was 59.19%.

As of Mar. 2023, Rayont has a Sloan Ratio of 59.19%, indicating earnings are more likely to be made up of accruals.


Rayont Sloan Ratio % Historical Data

The historical data trend for Rayont's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rayont Sloan Ratio % Chart

Rayont Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Jun22
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -523.53 -16.67 -186.30 2.43 39.76

Rayont Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.55 39.77 72.88 61.50 59.19

Competitive Comparison of Rayont's Sloan Ratio %

For the Packaged Foods subindustry, Rayont's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rayont's Sloan Ratio % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rayont's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Rayont's Sloan Ratio % falls into.



Rayont Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Rayont's Sloan Ratio for the fiscal year that ended in Jun. 2022 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2022 )-Cash Flow from Operations (A: Jun. 2022 )
-Cash Flow from Investing (A: Jun. 2022 ))/Total Assets (A: Jun. 2022 )
=(0.245--0.169
--5.229)/14.193
=39.76%

Rayont's Sloan Ratio for the quarter that ended in Mar. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2023 )
=(0.71-0.033
--5.197)/9.924
=59.19%

Rayont's Net Income for the trailing twelve months (TTM) ended in Mar. 2023 was 0.779 (Jun. 2022 ) + 0.502 (Sep. 2022 ) + -0.302 (Dec. 2022 ) + -0.269 (Mar. 2023 ) = $0.71 Mil.
Rayont's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2023 was -0.442 (Jun. 2022 ) + 0.24 (Sep. 2022 ) + -0.013 (Dec. 2022 ) + 0.248 (Mar. 2023 ) = $0.03 Mil.
Rayont's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2023 was -4.354 (Jun. 2022 ) + -0.508 (Sep. 2022 ) + -0.129 (Dec. 2022 ) + -0.206 (Mar. 2023 ) = $-5.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rayont  (OTCPK:RAYT) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2023, Rayont has a Sloan Ratio of 59.19%, indicating earnings are more likely to be made up of accruals.


Rayont Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Rayont's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rayont (Rayont) Business Description

Traded in Other Exchanges
N/A
Address
228 Hamilton Avenue, 3rd Floor, Palo Alto, CA, USA, 94301
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Executives
Meng Leong Liew director 1313 N. GRAND AVE. #16, WALNUT CA 91789
Kha Foo Chin director, 10 percent owner, officer: President, Treasurer ROOM 1217 NORTH TOWER, CONORDIA PLAZA, NO 1 SCIENCE MUSEUM RD., TSIM SHA TSUI E, KOWLOON K3 NA